Log in

Relevant bibliographies by topics / Mechanism of action of electroconvulsive therapy / Books

To see the other types of publications on this topic, follow the link: Mechanism of action of electroconvulsive therapy.

Books on the topic 'Mechanism of action of electroconvulsive therapy'

Author: Grafiati

Published: 14 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Mechanism of action of electroconvulsive therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

International Conference on Tumor Necrosis Factor and Related Cytokines (2nd 1989 Napa, Calif.). Tumor necrosis factor: Structure, mechanism of action, role in disease and therapy. Edited by Bonavida Benjamin and Granger Gale. Basel: Karger, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Hannan, J. M. Abdul. Studies on the efficacy and mechanism of action of tropical plants for diabetes therapy. [S.l: The Author], 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Godfrey, Tunnicliff, Eison Arlene S, and Taylor Duncan P, eds. Buspirone: Mechanisms and clinical aspects. San Diego: Academic Press, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Godfraind, T. Calcium channel blockers. Boston, MA: Birkhauser Verlag, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

A, Hickman John, and Tritton Thomas R, eds. Cancer chemotherapy. Oxford: Blackwell Scientific Publications, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Calcium channel blockers. Basel: Birkhäuser Verlag, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Lithium: Actions and mechanisms. Washington, DC: American Psychiatric Press, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

N, Herrington Reginald, ed. Biological treatments in psychiatry. Oxford: Oxford University Press, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Biological treatments in psychiatry. 2nd ed. Oxford: Oxford University Press, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

1944-, Yaksh T. L., ed. Anesthesia: Biologic foundations. Philadelphia: Lippincott-Raven, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

A, Montgomery S., and Corn Timothy H, eds. Psychopharmacology of depression. Oxford: Oxford University Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

International Symposium on Molecular Aspects of Chemotherapy. (3rd 1991 Gdańsk, Poland). Molecular aspects of chemotherapy: Proceedings of the Third International Symposium on Molecular Aspects of Chemotherapy, Gdansk, Poland, June 19-21, 1991. Berlin: Springer-Verlag, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

L, Faingold Carl, and Fromm Gerhard H, eds. Drugs for control of epilepsy: Actions on neuronal networks involved in seizure disorders. Boca Raton, FL: CRC Press, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

1950-, Morstyn George, Foote MaryAnn, and Lieschke Graham J, eds. Hematopoietic growth factors in oncology: Basic science and clinical therapeutics. Totowa, N.J: Humana Press, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

C, Dale David, and SpringerLink (Online service), eds. Hematopoietic Growth Factors in Oncology. Boston, MA: Springer Science+Business Media, LLC, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Godfrey, Tunnicliff, and Raess B. U, eds. GABA mechanisms in epilepsy. New York: Wiley-Liss, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

M, Pinedo H., and Schornagel J. H, eds. Platinum and other metal coordination compounds in cancer chemotherapy 2. New York: Plenum Press, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy (6th 1991 San Diego, Calif.). Platinum and other metal coordination compounds in cancer chemotherapy. New York: Plenum Press, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

1960-, Ozawa H., Saito Toshikazu, Takahata Naohiko 1932-, Nihon Seishin Shinkei Gakkai, and Symposium on Affective Disorders and Neuronal Signal Transduction (1996 : Sapporo-shi, Japan), eds. Signal transduction in affective disorders. Tokyo: Springer, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Fever and antipyresis: The role of the nervous system. Cambridge: Cambridge University Press, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

W, Thomson Angus, ed. The Molecular biology of immunosuppression. Chichester: Wiley, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

J, Garland C., and Angus James A, eds. The pharmacology of vascular smooth muscle. Oxford: Oxford University Press, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

1946-, Stephens David N., ed. Anxiolytic [Beta]-carbolines: From molecular biology to the clinic. Berlin: Springer-Verlag, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Ross, Lisa. Electroconvulsive Therapy. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190495756.003.0029.

Full text

Abstract:

The anesthetic management of patients who receive electroconvulsive therapy (ECT) for various psychiatric conditions in both the inpatient and the outpatient settings must take into account a number factors, such as its associated physiologic responses, existing comorbidities, medication management, monitoring, complications, and contraindications in order for it to remain a safe procedure. This chapter reviews the indications for ECT, the preprocedure anesthetic evaluation; theories regarding the therapeutic mechanism of action leading to the efficacy of ECT; cerebrovascular, cardiovascular, and neuroendocrine responses and monitoring standards. Furthermore, it discusses the selection of medications for induction, inhalational agents, and muscle relaxants as well as common drug interactions and premedication practices. The chapter culminates with an assessment of the morbidity and mortality associated with ECT both anesthetic and nonanesthetic related.

APA, Harvard, Vancouver, ISO, and other styles

25

(Editor), Kenneth S. Korach, Alexander Hillisch (Editor), and K. H. Fritzemeier (Editor), eds. New Molecular Mechanisms of Estrogen Action and Their Impact on Future Perspectives in Estrogen Therapy. Springer, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Tunnicliff, Godfrey, and Arlene S. Eison. Buspirone: Mechanisms and Clinical Aspects. Academic Pr, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Tunnicliff, Godfrey, and Arlene S. Eison. Buspirone: Mechanisms and Clinical Aspects. Academic Pr, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Cognitive Enhancing Drugs (Milestones in Drug Therapy). Birkhäuser Basel, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

(Editor), Gale Granger, ed. Tumor Necrosis Factor: Structure, Mechanism of Action, Role in Disease and Therapy : 2nd International Conference on Tumor Necrosis Factor and Relat. S. Karger AG (Switzerland), 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Lunenfeld, B. GnRH Analogues: The State of the Art at the Millennium. Informa Healthcare, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Török, M. Estée, Fiona J. Cooke, and Ed Moran. Antiparasitic therapy. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199671328.003.0005.

Full text

Abstract:

This chapter provides a systematic summary of antiparasitic agents, grouped by class and mechanism of action. Each summary provides information on the mode of action, resistance mechanisms, pharmacology, and clinical use.

APA, Harvard, Vancouver, ISO, and other styles

32

Hematopoietic Growth Factors in Oncology (Cancer Drug Discovery and Development). Humana Press, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

El-Mallakh, Rif S. Lithium: Actions and Mechanisms. Progress in Psychiatry, No. 50. American Psychiatric Press, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Shugar, David, and Wojciech Rode. Molecular Aspects Of Chemotherapy. Springer, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Shugar, David. Molecular Aspects of Chemotherapy. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Molecular Aspects of Chemotherapy. Springer Verlag, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Borowski, Edward, David Shugar, and Wojciech Rode. Molecular Aspects of Chemotherapy: Proceedings of the Third International Symposium on Molecular Aspects of Chemotherapy Gdańsk, Poland June 19-21 1991. Springer London, Limited, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Morstyn, George, MaryAnn Foote, and Graham J. Lieschke. Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics. Humana Press, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Morstyn, George, MaryAnn Foote, and Graham J. Lieschke. Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics. Humana Press, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2. Springer, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Dale, David C., Gary H. Lyman, and Gary Lyman. Hematopoietic Growth Factors in Oncology. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Fallon, Marie T., and Nathan I. Cherny. Opioid therapy: optimizing analgesic outcomes. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199656097.003.0094.

Full text

Abstract:

Treatment with analgesic drugs is the mainstay of cancer pain management. The major group of drugs used in cancer pain management is the opioid analgesics. During the last 30 years, there has been a dramatic increase in our knowledge of the sites and mechanism of action of the opioids. The development of analytical methods has also been of great importance in facilitating pharmacokinetic studies of the disposition and fate of opioids in patients. More recently, advances in genomic research have indicated the potential importance of pharmacogenetic factors in the response to opioid analgesics. These studies have begun to offer us a better understanding of some of the sources of variation between individuals in their response to opioids and to suggest ways of minimizing some of their adverse effects. This chapter presents a comprehensive discussion of the pre-clinical pharmacology and clinical aspects of opioid analgesia and the principles of opioid administration.

APA, Harvard, Vancouver, ISO, and other styles

43

Hedqvist, Per, Sven-Erik Dahlen, and Bengt Samuelsson. Leukotrienes As Mediators of Asthma and Inflammation: Basic and Applied Research (Advances in Prostaglandin, Thromboxane, and Leukotriene Research). Lippincott Williams & Wilkins, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Rauch, Sheila A. M., and Israel Liberzon. Mechanisms of Action in Psychotherapy. Edited by Israel Liberzon and Kerry J. Ressler. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190215422.003.0019.

Full text

Abstract:

Therapy at its core is based on learning, and learning at its core is biological. Experience that is not in some way encoded in the brain and/or body is lost. This chapter provides a discussion of mechanisms of therapy research in PTSD in which the goal is to understand how PTSD therapy works. First, the chapter reviews what a mechanism is and how therapeutic mechanisms are examined. It then discusses the importance of therapeutic mechanisms research within the broader realm of mental health research. It focuses on prolonged exposure (PE) therapy for PTSD as an example of application of mechanisms research methodology and begins with the presentation of a theoretical model that builds on previous theory and mechanisms research to date. While much of this model is theoretical, the goal is to show how mechanisms research may apply to clinical practice to improve precision, efficiency, and efficacy.

APA, Harvard, Vancouver, ISO, and other styles

45

Wijdicks, Eelco F. M., and Sarah L. Clark. Antimicrobial Therapy for Central Nervous System Infections. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190684747.003.0011.

Full text

Abstract:

Broad-spectrum antibiotics—those that are bactericidal and able to penetrate the blood–brain barrier—must be administered to any patient with a suspected infection of the central nervous system (CNS). Antimicrobials should be selected with consideration of spectrum of activity, pharmacokinetics, mechanism of action, and need to be administered in a timely fashion. This chapter discusses antibiotics that provide good penetration of the central nervous system, and appropriate doses for these infections are outlined. Antiviral therapy for CNS infections is limited but complex. Antimicrobial therapy for fungal meningitis is well defined but rarely indicated. Understanding the spectrum of antimicrobials and dosing is essential knowledge in caring for patients in the neurosciences intensive care unit with CNS infections.

APA, Harvard, Vancouver, ISO, and other styles

46

Shorter, Edward, and Max Fink. L’Envoi. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190881191.003.0014.

Full text

Abstract:

The long history of catatonia is presently resolved into a systemic syndrome, identified by symptoms and signs, verified by tests, and fully resolved by defined means. Our skills in relieving catatonia are as successful as our treatment for neurosyphilis. Catatonia is best seen as a systemic medical, not a psychiatric disorder. Unresolved fear is a core feature in its pathophysiology. There are difficulties distinguishing catatonia from melancholia; the prompt resolution of both with induced seizures presents a challenge in understanding them. Are they related? Melancholia’s neuroendocrine abnormalities offer direction to neuroscience studies of catatonia and of the mechanism of electroconvulsive therapy (ECT).

APA, Harvard, Vancouver, ISO, and other styles

47

Garland, C. J. The Pharmacology of Vascular Smooth Muscle. Oxford University Press, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Stephens, David N. Anxiolytic B-Carbolines: From Molecular Biology to the Clinic (Psychopharmacology Series). Springer-Verlag Telos, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

Foo, Joanne, Benazir Saleem, and Philip G. Conaghan. Analgesics. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0078.

Full text

Abstract:

Pain is one of the commonest presenting symptoms of musculoskeletal disorders and may be one the hardest to treat successfully. The available analgesic options provide different modes of action and their ranks continue to expand with new agents, some with multiple target action. This chapter reviews currently available analgesics (paracetamol and opioids) used for managing musculoskeletal pain and the agents used for neuropathic pain, including their mechanism of action, pharmacokinetics and side effects. The role of neuroleptic agents is reviewed, and a brief outline of some newer therapies for the treatment of pain such as tapentadol, and a potential therapy, anti-nerve growth factor monoclonal antibodies.

APA, Harvard, Vancouver, ISO, and other styles

50

TENS-like devices. Oxford University Press, 2014. http://dx.doi.org/10.1093/med/9780199673278.003.0011.

Full text

Abstract:

TENS-like devices deliver electrical currents across the intact surface of the skin using pulse generators with technical output specifications that differ from a standard TENS device. Technological advances have resulted in reductions in the size and cost of electrotherapeutic devices with increasing varieties of self-administered hand-held TENS-like devices available to practitioners and the general public. The diversity of TENS-like devices available on the market makes synthesizing evidence difficult. The purpose of this chapter is to categorize TENS-like devices and briefly overview the characteristics, mechanism of action, and effectiveness of various TENS-like devices. The chapter covers high-voltage pulsed (Galvanic) current, microcurrent electrical therapy, low-intensity transcutaneous cranial electrical stimulation, transcutaneous spinal electroanalgesia, transcutaneous piezoelectric current, non-invasive interactive neurostimulation, action potential simulation and H-wave therapy, and transcutaneous electrical acupoint stimulation.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!